
Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA
Member of the Healthcare Council
Mark Tapsak, PhD, is an Assistant Professor of Chemistry at Bloomsburg University of Pennsylvania. Prior to joining Bloomsburg University, he was a Senior Scientist at DexCom in San Diego, CA. Dr. Tapsak has also worked for Medtronic in Minneapolis, MN. His academic experience centers on polymer synthesis, polymer characterization and analytical chemistry. Dr. Tapsak's industry experience utilized his polymer chemistry training in medical product innovation, project management, technology transfer, and intellectual property strategies. He holds 15 US patents on medical devices and materials. He is also listed on more than 30 patent applications still under review in this field. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Industry leaders need to work with the US Patent and Trademark office to keep US patents strong
April 24, 2008
Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA
Federal Court Sides With GlaxoSmithKline, Strikes Down Rules Issued by Patent Office | biz.yahoo.com
The USPTO is facing an epidemic amount of frivolous patents. This degrades their ability to review strong and potentially important patents in a timely manner. Although this particular change was struck down in Federal court, industry leaders need to work with the USPTO in order...
CooperVision enters US market with Avaira™ two-week silicone hydrogel contact lenses
April 16, 2008
Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA
CooperVision Introduces Avaira™ Two-Week Silicone Hydrogel Contact Lenses | www.coopervision.com
I’m not so sure that this is a leap forward for CooperVision. After long delays for the release of the Biofinity lens, a two-week version has just been released. The material properties are reportedly “nice”, but certainly scaled back from what was reportedly achieved with Comfilcon...
DexCom Makes Progress Towards Easier Glucose Monitoring
November 19, 2007
Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA
Dexcom says gets FDA OK to calibrate glucose monitoring system | www.reuters.com
It's not easy being small, especially in the world of medical devices. Big players leverage branding, large sales forces and deep R&D organizations when they bring technologies to market. Unfortunately, most products are incremental improvements at best. Rarely does the conservative healthcaremarket benefit...
All plastics are not created equal, choose wisely young biomedical engineer
October 22, 2007
Mark Tapsak, PhD, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA
Materials: Adding Sustainability to Product Development | www.devicelink.com
Material choices for the designer of medical devices are traditionally limited to those that already enjoy a proven track record. The use of truly new materials in a medical device is not only risky for the device manufacturer, but also for the material manufacturer. In particular, tissue contacting...
| Study Group Name | No. Members |
|---|---|
| Users of Mass Spectrometers in the U.S. | 93 |
Mark Tapsak, PhD has not participated in any GLG Live Meetings.